Cytarabine Dose for Acute Myeloid Leukemia REPLY

被引：0
|
作者：
Lowenberg, Bob [1 ]
机构：
[1] Erasmus Univ, Med Ctr, Rotterdam, Netherlands
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2011年 / 364卷 / 22期
关键词：
CHEMOTHERAPY; THERAPY; INDUCTION; ADULTS;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2168 / 2169
页数：2
相关论文
共 50 条
  • [1] Cytarabine Dose for Acute Myeloid Leukemia
    Lowenberg, Bob
    Pabst, Thomas
    Vellenga, Edo
    van Putten, Wim
    Schouten, Harry C.
    Graux, Carlos
    Ferrant, Augustin
    Sonneveld, Pieter
    Biemond, Bart J.
    Gratwohl, Alois
    de Greef, Georgine E.
    Verdonck, Leo F.
    Schaafsma, Martijn R.
    Gregor, Michael
    Theobald, Matthias
    Schanz, Urs
    Maertens, Johan
    Ossenkoppele, Gert J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (11) : 1027 - 1036
  • [2] Sense and nonsense of high-dose cytarabine for acute myeloid leukemia
    Lowenberg, Bob
    BLOOD, 2013, 121 (01) : 26 - 28
  • [3] Cytarabine and skin reactions in acute myeloid leukemia
    Grille, Sofia
    Guadagna, Regina
    Boada, Matilde
    Irigoin, Victoria
    Stevenazzi, Mariana
    Guillermo, Cecilia
    Diaz, Lilian
    MEDICINA-BUENOS AIRES, 2013, 73 (06) : 535 - 538
  • [4] Safety and feasibility of outpatient high-dose cytarabine and intermediate-dose cytarabine for consolidation therapy in acute myeloid leukemia
    Li, Wenhui
    Richter, Katherine
    Lee, Jamie
    McCarthy, Kevin
    Kubal, Timothy
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (08) : 1812 - 1818
  • [5] Outpatient consolidation chemotherapy with intermediate dose cytarabine has similar survival and relapses rates in acute myeloid leukemia as compared to high dose cytarabine: A single center analysis
    Sljivic, Igor
    Fulford, Adrienne
    Ho, Jenny
    Lazo-Langner, Alejandro
    Xenocostas, Anargyros
    Deotare, Uday
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 111 (06) : 888 - 894
  • [6] Induction of Acute Myeloid Leukemia with Idarubicin, Cytarabine and Cladribine
    Wiedower, Eric
    Jamy, Omer
    Martin, Michael G.
    ANTICANCER RESEARCH, 2015, 35 (11) : 6287 - 6290
  • [7] Comparison of consolidation strategies in acute myeloid leukemia: high-dose cytarabine alone versus intermediate-dose cytarabine combined with anthracyclines
    Kim, Dae Sik
    Kang, Ka-Won
    Lee, Se Ryeon
    Park, Yong
    Sung, Hwa Jung
    Kim, Seok Jin
    Choi, Chul Won
    Kim, Byung Soo
    ANNALS OF HEMATOLOGY, 2015, 94 (09) : 1485 - 1492
  • [8] Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients
    Roellig, C.
    Kramer, M.
    Gabrecht, M.
    Haenel, M.
    Herbst, R.
    Kaiser, U.
    Schmitz, N.
    Kullmer, J.
    Fetscher, S.
    Link, H.
    Mantoyani-Loeffler, L.
    Kruempelmann, U.
    Neuhaus, T.
    Heits, F.
    Einsele, H.
    Ritter, B.
    Bornhaeuser, M.
    Schetelig, J.
    Thiede, C.
    Mohr, B.
    Schaich, M.
    Platzbecker, U.
    Schaefer-Eckart, K.
    Kraemer, A.
    Berdel, W. E.
    Serve, H.
    Ehninger, G.
    Schuler, U. S.
    ANNALS OF ONCOLOGY, 2018, 29 (04) : 973 - 978
  • [9] Incidence of infection in patients with acute myeloid leukemia receiving high-dose cytarabine consolidation
    Mcclellan, Kristen
    Messina, Julia
    Saullo, Jennifer
    Huggins, Jonathan
    ANNALS OF HEMATOLOGY, 2024, 103 (12) : 5351 - 5358
  • [10] Toxicity and outcome of adults with acute myeloid leukemia receiving consolidation with high-dose cytarabine
    Lopes, Lais Moreira
    Nucci, Marcio
    Portugal, Rodrigo Doyle
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2024, 46 (04) : 397 - 401
12345